Author: Maria Bzówka; Karolina Mitusinska; Agata Raczynska; Aleksandra Samol; Jack Tuszynski; Artur Góra
Title: Molecular Dynamics Simulations Indicate the SARS-CoV-2 Mpro Is Not a Viable Target for Small-Molecule Inhibitors Design Document date: 2020_3_2
ID: mp3a9c9u_39
Snippet: FoldX software was used to insert substitutions into the structures of SARS-CoV and SARS-CoV-2 Mpros. To analyse the changes in the two structures, 12 single-point mutations were introduced to the SARS structure. Each of the residues in SARS-CoV Mpro was mutated to the respective SARS-CoV-2 Mpro residue, and the difference in total energies of the wild-type SARS-CoV-2 Mpro and the mutant structures were calculated. Then, to investigate further po.....
Document: FoldX software was used to insert substitutions into the structures of SARS-CoV and SARS-CoV-2 Mpros. To analyse the changes in the two structures, 12 single-point mutations were introduced to the SARS structure. Each of the residues in SARS-CoV Mpro was mutated to the respective SARS-CoV-2 Mpro residue, and the difference in total energies of the wild-type SARS-CoV-2 Mpro and the mutant structures were calculated. Then, to investigate further possible mutations of SARS-CoV-2 Mpro, single nucleotide substitutions were introduced to the SARS-CoV-2 main protease gene. If a substitution of a single nucleotide caused translation to a different amino acid than the corresponding residue in the wild-type structure, an appropriate mutation was proposed with FoldX software.
Search related documents:
Co phrase search for related documents- amino acid and correspond residue: 1
- amino acid and main protease gene: 1
- amino acid and Mpro residue: 1, 2
- amino acid and mutant structure: 1, 2, 3, 4, 5, 6
- amino acid and nucleotide substitution: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
- amino acid and possible mutation: 1, 2, 3, 4
- amino acid and protease gene: 1, 2, 3, 4, 5, 6, 7, 8, 9
- amino acid and SARS CoV Mpro residue: 1
- amino acid and SARS main protease gene: 1
- amino acid and SARS Mpro residue: 1
- amino acid and SARS structure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76
- amino acid and single nucleotide: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- amino acid and single nucleotide substitution: 1, 2, 3, 4, 5, 6, 7
- amino acid and single point: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- amino acid and single point mutation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- amino acid and structure change: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- amino acid and total energy: 1, 2, 3, 4
- amino acid and wild type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- amino acid and wild type structure: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date